Streetbeat News

Earnings

CCL

CUK

Carnival Corporation expects an adjusted EPS impact of $0.07-$0.08 for 2024 due to rerouting in the Red Sea, primarily affecting Q2. The company reports no impact on booking trends from the Red Sea situation and has no further Red Sea transits planned until November 2024.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:18 pm

HITI

High Tide Inc. (NASDAQ:HITI) reported a 37% year-over-year revenue growth for 2023, with total revenue reaching CA$487.7 million. The company also saw a 40% quarter-over-quarter increase in free cash flow in Q4, and a reduction in net loss from CA$52.5 million in Q4 2022 to CA$31.8 million in Q4 2023. Adjusted EBITDA for the year was up 110% compared to 2022. After the announcement, HITI shares traded 2.59% higher at $1.98 per share after hours.

Portfolio Pulse from Jelena Martinovic

January 30, 2024 | 2:13 pm

RRBI

Red River Bancshares (NASDAQ:RRBI) reported Q4 2023 adjusted earnings per share (EPS) of $1.16, surpassing the analyst consensus estimate of $0.99 by 17.17%.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:09 pm

NVR

NVR, Inc. reported Q4 2023 adjusted earnings per share (EPS) of $121.56, slightly beating the consensus estimate of $121.50. However, the company's sales for the quarter were $2.43 billion, falling short of the $2.59 billion estimate, marking a 10.40% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:04 pm

MBUU

Malibu Boats, Inc. (MBUU) reported mixed financial results for Q2, leading to a decline in its stock price.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:02 pm

MA

Mastercard (NYSE:MA) is expected to release its quarterly earnings report on January 31, 2024, with an estimated EPS of $3.08. Investors are looking for an earnings beat and positive guidance for future growth. Historically, Mastercard's stock price has shown minor fluctuations following earnings reports, regardless of beats or misses. The stock is currently trading at $440.58, up 16.9% over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 2:02 pm

FTV

Fortive (NYSE:FTV) is expected to release its quarterly earnings report on January 31, 2024, with an estimated EPS of $0.94. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, Fortive's stock price has shown varied reactions to earnings reports. Shares are currently trading at $74.69, up 13.39% over the last 52 weeks. The company's past earnings performance shows a mix of exact matches and beats to EPS estimates, with corresponding modest stock price changes.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 2:01 pm

GSK

GSK (NYSE:GSK) is expected to release its quarterly earnings report on January 31, 2024, with an estimated EPS of $0.75. Investors are looking for an earnings beat and positive guidance for future growth. Historically, GSK's stock price has shown mixed reactions to earnings reports, with a slight drop following the last report despite beating EPS estimates. Over the past year, GSK shares have risen by 10.65%, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 2:01 pm

TEVA

Teva Pharmaceutical Industries (NYSE:TEVA) is scheduled to release its quarterly earnings report on January 31, 2024. Analysts predict an EPS of $0.76. Investors are looking for an earnings beat and positive guidance for future growth. Historically, TEVA's stock price has been sensitive to earnings performance and guidance. Last quarter, TEVA missed EPS estimates by $0.01, resulting in a 4.15% share price decline. Over the past year, TEVA shares have increased by 11.6%.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 2:01 pm

OTIS

Otis Worldwide (NYSE:OTIS) is scheduled to release its quarterly earnings report on January 31, 2024. Analysts predict an EPS of $0.86. Investors will be looking for an earnings beat and positive guidance for future growth. Historically, OTIS's stock price has shown modest reactions to earnings beats or misses. Shares are currently trading at $89.32, with a 5.63% increase over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 2:01 pm